Key Points
- Itron SVP Donald Reeves III sold 293 shares on May 27 at an average price of $84.50, for a total of $24,758.50. The sale was made under a pre-arranged Rule 10b5-1 plan, and he still held 28,807 shares afterward.
- Itron beat quarterly earnings expectations in its latest report, posting $1.49 EPS versus the $1.26 consensus. Revenue came in at $586.98 million, slightly above estimates, though sales were down 3.3% year over year.
- Analyst sentiment remains constructive, with eight Buy ratings, four Hold ratings, and one Sell rating. The stock’s consensus price target is $131.22, well above its recent trading level near $83.59.
Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Donald Reeves III sold 293 shares of the firm's stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $84.50, for a total transaction of $24,758.50. Following the sale, the senior vice president directly owned 28,807 shares of the company's stock, valued at approximately $2,434,191.50. The trade was a 1.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Itron Price Performance
ITRI opened at $83.59 on Friday. The company has a fifty day simple moving average of $87.89 and a 200 day simple moving average of $93.81. The firm has a market cap of $3.71 billion, a price-to-earnings ratio of 13.33, a PEG ratio of 0.75 and a beta of 1.35. Itron, Inc. has a twelve month low of $77.77 and a twelve month high of $142.00. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97.
Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. During the same period last year, the business earned $1.52 EPS. The business's revenue was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Equities research analysts expect that Itron, Inc. will post 6.01 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Zacks Research upgraded shares of Itron from a "strong sell" rating to a "hold" rating in a research note on Thursday, February 26th. Guggenheim set a $155.00 target price on shares of Itron in a research note on Friday, February 13th. Stephens restated an "overweight" rating and issued a $130.00 target price on shares of Itron in a research note on Wednesday, May 20th. JPMorgan Chase & Co. cut their target price on shares of Itron from $133.00 to $113.00 and set an "overweight" rating on the stock in a research note on Thursday, April 16th. Finally, Raymond James Financial assumed coverage on shares of Itron in a research note on Tuesday, April 21st. They issued an "underperform" rating on the stock. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Itron currently has an average rating of "Moderate Buy" and a consensus price target of $131.22.
Read Our Latest Research Report on ITRI
Institutional Trading of Itron
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. boosted its holdings in Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company's stock worth $46,000 after buying an additional 268 shares in the last quarter. M&T Bank Corp boosted its holdings in Itron by 10.0% during the second quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company's stock worth $282,000 after buying an additional 194 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock worth $53,000 after buying an additional 81 shares in the last quarter. Jump Financial LLC bought a new stake in Itron during the second quarter worth approximately $1,609,000. Finally, Cerity Partners LLC boosted its holdings in Itron by 10.2% during the second quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company's stock worth $715,000 after buying an additional 503 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors.
Itron Company Profile
(
Get Free Report)
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
